Vega J D, Kanter K R, Lawrence E C
Division of Cardiothoracic Surgery/Department of Surgery, Emory University School of Medicine, Atlanta, USA.
J Med Assoc Ga. 1998 Apr;87(2):105-7.
Lung transplantation is a viable therapeutic option for patients with end-stage lung disease. Quality of life and survival are improved for most recipients. Donor availability remains an impediment to widespread application. The development of OB after lung transplantation continues to affect long-term survival. Clinical and basic science research will provide new strategies to further improve results.
肺移植是终末期肺病患者可行的治疗选择。大多数接受者的生活质量和生存率都有所提高。供体的可获得性仍然是广泛应用的一个障碍。肺移植后闭塞性细支气管炎（OB）的发展继续影响长期生存。临床和基础科学研究将提供进一步改善治疗效果的新策略。
